医学
养生
内科学
癌症
肿瘤科
胃肠病学
一线治疗
化疗
作者
Lingyun Zhang,Bin Guan,Wei Li,Shan Yu,Qian Li,Yiyi Yu,Yuehong Cui,Debin Sun,Yan Wang
摘要
The results suggested that patients with HER2-positive GC could benefit from PD-1 inhibitors combination with trastuzumab and chemotherapy, especially patients with HER-2 FISH more than six and TP53 mutations.
科研通智能强力驱动
Strongly Powered by AbleSci AI